AMY NISTICO: Open Payments
NPI 1043948151 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 27 payments from 10 companies in 2025. Trend: 2023 $1,341 · 2024 $1,093 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 6 | $195 |
| Lundbeck LLC | 3 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Alkermes, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| ABBVIE INC. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: SPRAVATO, REXULTI, INGREZZA, Auvelity, ARISTADA, CAPLYTA, AUSTEDO XR, VRAYLAR.
Industry payments across NY — which companies pay providers there.
